Phar­ma fees to Eu­ro­pean reg­u­la­tor spike thanks to 10% in­fla­tion rate

Phar­ma com­pa­nies sub­mit­ting mar­ket­ing au­tho­riza­tions with a full dossier to the Eu­ro­pean Med­i­cines Agency are go­ing to pay more than $35,000 (€32,600) more in 2023 than 2022, thanks to an in­fla­tion rate of 10.4%, the EMA said Fri­day.

The new fees, which took ef­fect at the be­gin­ning of this month, fea­ture in­creas­es across the board, with sci­en­tif­ic ad­vice from the Eu­ro­pean reg­u­la­tors now cost­ing any­where from about $56,000 (€51,800) to about $113,000 (€103,800), up more than $20,000 from 2022 fees on the high­er end.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER